SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Trump wants to create an “AI Force”: Gemini incident shows why security must change

Autonomous remediation won't arrive as a big red button

CTech's Book Review: You cannot defend what you cannot see or understand

Nashville summit connects Israeli healthtech startups with U.S. healthcare leaders

Buzz

Most popular

Daily

Weekly

1

Oracle co-CEO sells $3.4 million in shares as stock falls 56% one year after his appointment

2

Israeli defense giants head to Marrakech as Morocco deepens military ties

3

The Israeli entrepreneur who built a university for 271,000 students around the world

4

Island raises $400 million at $6.4 billion valuation as AI agents reshape enterprise security

5

Brookfield closes in on $2 billion deal for Nice’s Actimize

Nestlé

3 stories about Nestlé

גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki

Investors are hopeful, but the company must now face an uphill battle in a crowded market.

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

A Beloved Israeli Snack Prepares to Take Bigger Bite Out of American Market

07.02.19|Navit Zomer

Generations of Israeli kids grew up eating peanut butter flavored snack Bamba. Now, manufacturer Osem is negotiating a distribution agreement that could make the snack as wildly popular with American kids